Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Does Aveo's Tivozanib Work, or Not? | Main | Getting Drug Research Really, Really Wrong »

August 8, 2012

Closure at the Neurosciences Institute?

Email This Entry

Posted by Derek

There doesn't seem to be any mention of it on their web site, but the Neurosciences Institute in San Diego/La Jolla may be closing up shop. A reader received an e-mail about a lab equipment auction at that address, and sure enough, there's an "online lab liquidation auction" being held by BioSurplus. They mention in passing that ". . .The Institute is now shutting down its lab spaces", but I can't find any other mention of what's happened.

Comments (12) + TrackBacks (0) | Category: The Central Nervous System


COMMENTS

1. Anon on August 8, 2012 9:22 AM writes...

Seems like the auditorium was recently transferred over to Scripps control too: http://www.scripps.edu/news/press/2012/20120801auditorium.html

Permalink to Comment

2. MolecularGeek on August 8, 2012 9:26 AM writes...

Considering that they haven't had a press release in nearly two years, and the news section of the site hasn't been updated in over a year, it doesn't look good at all.

Permalink to Comment

3. pjay on August 8, 2012 10:06 AM writes...

People have been let go beginning early last year. Two major donors are no longer going to support the NSI.

Permalink to Comment

4. Milfshake on August 8, 2012 2:06 PM writes...

On the bright side we still have this 70 million dollar abortion:

http://en.wikipedia.org/wiki/Lou_Ruvo_Center_for_Brain_Health


Not that any research goes on there, of course. (Unless being a satellite site for clinical trials counts.) One wonders what the NSI could have done with that 100 mil. Bummer.

Permalink to Comment

5. @4 on August 8, 2012 2:40 PM writes...

Reminds of the Stata Center at MIT. Gehry is such a charlatan architect!

Permalink to Comment

6. Jonathan on August 8, 2012 3:14 PM writes...

I used to love walking through NSI on my way to my building at Scripps. It always felt suitably space age.

Permalink to Comment

7. MTK on August 8, 2012 5:30 PM writes...

@4,

Milfshake?

Sounds like something on late Saturday on Cinemax.

Permalink to Comment

8. Anonymous on August 8, 2012 6:06 PM writes...

It is always easier to design and build buildings especially flashy buildings with donors' names imprinted on them than it is to actually invent real drugs. It is also cheaper and much lower risk to buy buildings than pay the scientists who will invent these drugs.

Permalink to Comment

9. anon on August 8, 2012 7:36 PM writes...

Ah, I wondered what the 'auction this way' sign meant on my way into the lab this morning

Permalink to Comment

10. MoMo on August 9, 2012 10:21 AM writes...

What is it with brain institutes and their ultra-modern neo-fascist industrial buildings? Like the Picower at MIT-everyone there should dress like the Jetsons.

Too bad they spent all their money on buildings, now all they are good for now are German techno-beat scat parties.

Is this a sign brains are out of fashion in science?

Now we dance!

Permalink to Comment

11. Anonymous on August 9, 2012 2:47 PM writes...

Looks like their lease ran out, and their Scientific Director will be releasing information regarding their plans..

http://www.lajollalight.com/2012/08/08/neurosciences-venue-now-under-scripps-research-auspices/

Permalink to Comment

12. Anonymous on August 10, 2012 4:58 AM writes...

For what appears to be the final word on this one.

http://blogs.nature.com/news/2012/08/neuroscience-institute-to-move-from-architectural-icon-into-office-space.html

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
A Last Summer Day Off
The Early FDA
Drug Repurposing
The Smallest Drugs
Life Is Too Short For Some Journal Feeds
A New Look at Phenotypic Screening
Small Molecules - Really, Really Small
InterMune Bought